期刊
GYNECOLOGIC ONCOLOGY REPORTS
卷 26, 期 -, 页码 91-93出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.gore.2018.10.011
关键词
-
资金
- Clovis Oncology
A 56-year old woman with BRCA-associated breast cancer and recurrent ovarian cancer was treated with a poly (ADP-ribose) polymerase enzyme ( PARP) inhibitor, rucaparib, in the setting of dialysis-dependence which required dose modification. Rucaparib trough levels were obtained before and after dialysis and a clinically significant disease response was appreciated.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据